News Reports / Healthcare / VEEV
VEEVVeeva Systems Inc.
NYSE · Healthcare · Mkt cap $49.0B · Avg vol 1.67M
$302.58
-7.52 (-2.42%)
Quote as of November 6, 2026, 1:14 PM ET
News Impact Report · Published November 6, 2026, 9:52 AM ET
VEEV: Veeva Systems Reports Q2 FY2027 Revenue of $1.55B, Net Income of $428.5M
Price: $300.92 | Today's Change: -2.97%
What Happened
Veeva Systems Inc. filed an 8-K with the SEC on November 6, 2026 (Items 2.02 and 9.01), disclosing its financial results for the second quarter of fiscal year 2027. Revenue for the quarter reached $1.548 billion, while net income came in at $428.5 million. Diluted earnings per share were $2.56, with basic EPS of $2.63.
Why It Matters
For investors, the headline numbers illustrate the scale of Veeva's growth trajectory. To put the top line in perspective, revenues of $511.7 million were reported as recently as Q2 FY2021 — meaning quarterly revenue has effectively tripled over roughly six fiscal years. Operating income of $429.6 million in Q2 FY2027 closely tracks net income, suggesting limited non-operating drag and a highly efficient conversion of revenue to profit at the operating level. The stock's current price of $300.92 sits above StockWatch's previously published coverage price target, though the market's -2.97% reaction on the day suggests investors may be re-calibrating expectations around near-term growth guidance or other forward-looking disclosures in the full filing detail.
Analysis
The Q2 FY2027 results reflect a company that has continued to compound revenue at a substantial pace since our existing coverage was initiated in September 2026. The near-perfect alignment between operating income ($429.6M) and net income ($428.5M) is notable — it indicates that interest, tax, and other below-the-line items are roughly net-neutral this quarter, underscoring the operational quality of earnings.
The modest negative price action on the filing date warrants watching. When a profitable, high-margin software company sells off on earnings day despite strong absolute results, it often signals that the market's focus has shifted to forward guidance, renewal trends, or specific segment commentary contained elsewhere in the full earnings release and supplemental materials filed under Item 9.01.
Key things to monitor going forward:
- Revenue growth rate trends — whether the year-over-year pace is accelerating, stabilizing, or moderating
- Operating margin trajectory — Q2 FY2027 operating income of $429.6M on revenue of $1.548B implies a roughly 27.7% operating margin, a figure worth tracking quarter-over-quarter
- Any commentary on Vault CRM adoption or Data Cloud segment performance, which are central to Veeva's long-term expansion thesis in the life sciences vertical
Disclaimer
This report is a news and informational summary based solely on data contained in Veeva Systems' SEC filing dated November 6, 2026, and structured financial facts extracted from its official XBRL data. It does not constitute investment advice, a recommendation to buy or sell any security, or a research rating of any kind. Investors should conduct their own due diligence and consult a qualified financial professional before making any investment decisions.
Existing Coverage
StockWatch has full coverage on VEEV, published 2026-09-23. Read our Initiating Coverage →
Source
Filed with the SEC on 2026-11-06. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1393052/000139305226000039/veev-20261105.htm
Key Data
Last
$300.92
P&L ($)
$-9.23
P&L (%)
-2.97%
Day Range
$294.99 - $303.53
Volume
69.43K
Market Cap
$49.0B
Previous Close
$310.14
Open
$296.96
52 Week Range
$148.05 - $325.99
Shares Outstanding
161.91M
Public Float
148.27M
Average Volume
1.67M
As of November 6, 2026, 10:46 AM ET